Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Open Access

Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

DOI Full Paper Access

38

Citations

21

References

2017

Year

Erik S.G. Stroes, Andrey V. Susekov, Tjerk W.A. de Bruin, Mats Kvarnström, Hong Yang, Michael H. Davidson

Journal of clinical lipidology

Abstract

An intermediate dose of OM3-CA (2 g daily) significantly lowers TG and non-high-density lipoprotein cholesterol concentrations in patients with SHTG and may benefit individuals at risk of acute pancreatitis and cardiovascular disease.

References

	Year	Citations

Page 1